Can an MRI nomogram help predict if my locally advanced rectal cancer is high-risk?

For locally advanced rectal cancer (LARC), knowing whether your tumor is high-risk is crucial for choosing the right treatment. Standard MRI scans have limits in capturing the full complexity of the tumor. A nomogram is a tool that combines multiple pieces of information — like MRI features and clinical details — into a single risk score. Recent studies show that MRI-based nomograms, especially those using habitat radiomics (which looks at different regions within the tumor), can predict high-risk LARC and outcomes like liver metastasis more accurately than older methods ²⁶.

What the research says

A 2024 multicenter study of 290 LARC patients developed a nomogram that combined MRI habitat heterogeneity (different tumor zones) with peritumoral radiomics (features from tissue around the tumor) and clinical variables. This nomogram outperformed single-feature models in identifying high-risk LARC, with better calibration and clinical net benefit ². Another two-center study of 385 patients used habitat radiomics from MRI to predict metachronous liver metastasis (MLM) — a key high-risk event. The integrated nomogram achieved AUCs of 0.959, 0.925, and 0.889 in training, internal validation, and external test sets, showing excellent predictive power ⁶.

Other MRI-based nomograms have also been developed. A multicenter study of 634 patients created a nomogram combining radiomics and clinical features to predict tumor downstaging after chemoradiotherapy, helping identify patients who might benefit from organ preservation ⁷. A separate study used DCE-MRI radiomics to predict HIF-1α expression, a marker linked to treatment response, with a nomogram achieving AUCs of 0.89 and 0.82 in training and validation cohorts ⁸.

These nomograms are not yet standard in all clinics, but they represent a significant advance over conventional MRI staging. They can help doctors decide who might need more aggressive therapy, such as total neoadjuvant therapy (TNT), versus who could safely receive less intensive treatment ²⁶.

What to ask your doctor

• Is an MRI-based nomogram available at your center to help assess my risk level?
• How would knowing my habitat radiomics score change my treatment options?
• Could a nomogram help decide if I need total neoadjuvant therapy (TNT) or can have a less intensive approach?
• Are there any ongoing studies or clinical trials using MRI nomograms for rectal cancer at your hospital?
• How does the nomogram's prediction compare with other risk tools you use?